文献速递创伤与烧伤呼吸衰竭与机械通气重症综合管理与镇静镇痛

严重创伤合并胸部创伤患者的肺炎:一项回顾性观察性多中心研究结果

Pneumonia in severely injured patients with thoracic trauma: results of a retrospective observational multi-centre study.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2019-03-14
一句话结论严重创伤合并胸部创伤患者肺炎发生率27.5%,年龄、男性、误吸和机械通气时长是独立预测因素,机械通气时长最佳判别界值为102小时。

该研究基于TraumaRegister DGU®数据,纳入1162例严重创伤合并胸部创伤的成人患者,评估肺炎发生情况及相关因素。肺炎总体发生率为27.5%。肺炎患者较无肺炎患者损伤更重(平均ISS 32.6 vs 25.4)、年龄更大(平均51.3岁 vs 47.5岁)、机械通气时间更长(平均368.9小时 vs 114.9小时)。多因素分析显示年龄、男性、误吸和机械通气时长是肺炎发生的独立预测因素;区分是否发生肺炎的机械通气时长最佳界值为102小时。胸部创伤程度(AISthorax)、ISS和肺部合并症在多因素分析中与肺炎发生率无显著关联;肺炎组与无肺炎组死亡率无显著差异。

要点

  • 严重创伤合并胸部创伤患者肺炎总体发生率为27.5%(1162例)。
  • 肺炎患者平均ISS 32.6 vs 无肺炎患者25.4,平均年龄51.3岁 vs 47.5岁,平均机械通气368.9小时 vs 114.9小时。
  • 多因素分析中年龄、男性、误吸和机械通气时长均为肺炎发生的独立预测因素。
  • 区分住院期间是否发生肺炎的机械通气时长最佳界值为102小时。
  • AISthorax、ISS和肺部合并症在多因素分析中与肺炎发生率无显著关联,肺炎组与无肺炎组死亡率无显著差异。

适用人群与场景

  • TraumaRegister DGU®中记录的严重创伤合并胸部创伤的成人患者,共1162例。
  • 来自与TraumaRegister DGU®关联的Level-I大学创伤中心。

诊断标准与关键阈值

  • 机械通气时长区分住院期间是否发生肺炎的最佳界值为102小时。

研究设计与关键结果

  • 研究类型:回顾性观察性多中心研究,纳入1162例严重创伤合并胸部创伤的成人患者,数据来自TraumaRegister DGU®。
  • 肺炎总体发生率为27.5%。
  • 肺炎患者与无肺炎患者比较:平均ISS 32.6 vs 25.4,平均年龄51.3岁 vs 47.5岁,平均机械通气时长368.9小时 vs 114.9小时。
  • 多因素分析显示年龄、男性、误吸和机械通气时长为肺炎发生的独立预测因素。
  • 区分住院期间是否发生肺炎的机械通气时长最佳界值为102小时。
  • 多因素分析中胸部创伤程度(AISthorax)、ISS和肺部合并症与肺炎发生率无显著关联。
  • 肺炎组与无肺炎组死亡率无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性病历审查,证据等级Level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于严重创伤合并胸部创伤的成人患者,年龄较大、男性、存在误吸及机械通气时间较长者肺炎风险更高,机械通气时长102小时可作为判别肺炎风险的参考界值。
  • 原文结论指出,年龄、误吸和机械通气时长与肺炎发生相关,但这些参数未发现与患者有无肺炎的结局差异相关;作者认为未来研究应关注独立参数以更清晰识别肺炎高风险的严重创伤亚组。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While the incidence and aspects of pneumonia in ICU patients has been extensively discussed in the literature, studies on the occurrence of pneumonia in severely injured patients are rare. The aim of the present study is to elucidate factors associated with the occurrence of pneumonia in severely injured patients with thoracic trauma.

SETTING: Level-I University Trauma Centres associated with the TraumaRegister DGU®.

METHODS: A total of 1162 severely injured adult patients with thoracic trauma documented in the TraumaRegister DGU® (TR-DGU) were included in this study. Demographic data, injury severity, duration of mechanical ventilation (MV), duration of ICU stay, occurrence of pneumonia, bronchoalveolar lavage, aspiration, pathogen details, and incidences of mortality were evaluated. Statistical evaluation was performed using SPSS (Version 25.0, SPSS, Inc.) software.

RESULTS: The overall incidence of pneumonia was 27.5%. Compared to patients without pneumonia, patients with pneumonia had sustained more severe injuries (mean ISS: 32.6 vs. 25.4), were older (mean age: 51.3 vs. 47.5) and spent longer periods under MV (mean: 368.9 h vs. 114.9 h). Age, sex (male), aspiration, and duration of MV were all independent predictors for pneumonia occurrence in a multivariate analysis. The cut-off point for duration of MV that best discriminated between patients who would and would not develop pneumonia during their hospital stay was 102 h. The extent of thoracic trauma (AISthorax), ISS, and presence of pulmonary comorbidities did not show significant associations to pneumonia incidence in our multivariate analysis. No significant difference in mortality between patients with and without pneumonia was observed.

CONCLUSIONS: Likelihood of pneumonia increases with age, aspiration, and duration of MV. These parameters were not found to be associated with differences in outcomes between patients with and without pneumonia. Future studies should focus on independent parameters to more clearly identify severely injured subgroups with a high risk of developing pneumonia.

LEVEL OF EVIDENCE: Level II - Retrospective medical record review.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Wutzler S, Bläsius FM, Störmann P, et al. Pneumonia in severely injured patients with thoracic trauma: results of a retrospective observational multi-centre study. Scand J Trauma Resusc Emerg Med. 2019. PMID: 30871601. doi:10.1186/s13049-019-0608-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。